Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
avian influenza
Biotech
CEPI to fund Moderna's pandemic flu trial after HHS walked away
With support from the U.S. government evaporated, Moderna is leaning on an old ally to carry plans for its prospective mRNA bird flu vaccine forward.
Fraiser Kansteiner
Dec 18, 2025 9:40am
HHS reevaluates $590M bird flu deal with Moderna: report
Feb 27, 2025 11:07am
CDC data on influenza, bird flu go missing as outbreaks escalate
Feb 19, 2025 9:45am
AstraZeneca antibody protects monkeys from severe bird flu
Jan 30, 2025 2:00pm
CureVac gains $430M GSK vaccine contract, loses 30% of staff
Jul 3, 2024 5:00am
NIAID is 'on the ball' with bird flu research, but gaps remain
Jun 10, 2024 5:50am
